Overview / Abstract: |
In this case-based discussion, Dr. Longenecker and Dr. Okeke discuss therapy selection for HIV-positive individuals at-risk for CVD. Topics include the importance of early initiation of ART, selecting ART for HIV-positive individuals with dyslipidemia, considerations for viral suppression in the setting of CVD risk factors, and ongoing clinical trials. This is the third activity of a four-part series. Upon completion of this activity, participants will be able to: HIV-infected individuals have an increased risk of CVD. Research has identified characteristics of HIV infection itself that influence CVD risks, yet their precise roles and potential as therapeutic targets are unclear. Initiation of ART and management of traditional CVD risk factors are paramount to reducing risk, but additional strategies are needed. This activity is designed for cardiologists, infectious disease specialists, primary care physicians, and other clinicians interested in the management of patients with HIV-related cardiovascular disease. |
Expiration |
Nov 07, 2018 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
0.75 AMA PRA Category 1 Credit(s) |
Accreditation |
ACCME |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Chris Longenecker, MD N. Lance Okeke, MD |
Activity Specialities / Related Topics |
Cardiology / Cardiovascular, Education / Teaching, Family Medicine, HIV / AIDS, Infectious Disease, Internal Medicine, Primary Care, STD's / Sexually Transmitted Disease |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Gilead Sciences, Inc. |
Keywords / Search Terms |
ACHL Cardiology, Cardiovascular, HIV, Infectious Disease, live/online CME, Gilead, Gilead Sciences, enewsletter, CVD HIV, HIV CVD, ART, REPRIEVE, Chris Longenecker, Longenecker, Lance Okeke, Okeke, ACHL, ACHLcme, Gilead, Free CE CME Live CE CME |